Article
European Biosimilar Updates – Formycon's Ustekinumab And Alvotech's Cetrolizumab Pegol
On June 26, 2025, Formycon AG ("Formycon") announced a distribution agreement with Teva Group subsidiary Ratiopharm GmbH ("Ratiopharm") for the semi-exclusive commercialization...
Goodwin Procter LLP